Kaiser Health News
The U.S. government has invested billions of dollars in manufacturing, used a wartime act dozens of times to boost supplies and yet there’s still not enough covid vaccine on the way to meet demand - or even the government’s own goals for national immunization.
Please share this article - Go to very top of page, right hand side, for social media buttons.
President Joe Biden, in remarks at the National Institutes of Health this month, said the nation is “now on track to have enough supply for 300 million Americans by the end of July. But at the current rate of production, Pfizer and Moderna will miss their targets of providing at least 100 million doses each by the end of March, let alone 200 million more doses each has promised by July.
Biden vaccine victories build on Trump team s work
Dan Diamond and Isaac Stanley-Becker, The Washington Post
March 11, 2021
FacebookTwitterEmail
President Joe Biden listens Wednesday as leaders from Johnson & Johnson and Merck spoke during an event at the White House.Washington Post photo by Jabin Botsford
WASHINGTON - President Joe Biden beckoned leaders of two of the world s largest pharmaceutical companies to the White House on Wednesday and credited his administration for the nearly unprecedented collaboration between the longtime rivals, Merck and Johnson & Johnson, now jointly producing acoronavirus vaccine.
But the breakthrough touted by Biden was first conceived by Trump officials last year, culminating in a Jan. 4 conference call arranged between Merck and Johnson & Johnson s senior leaders, said four Trump administration officials with knowledge of the efforts.
Excerpts from recent editorials in the United States and abroad: March 10 The Virginian Pilot & Daily Press on marking one year since the World Health Organization announced that COVID-19 was a global pandemic: Where were you when the world stopped? It’s a grim question, one with answers unique to every individual who has […]